Insider Transactions in Q2 2023 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Spencer R Berthelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+7.43%
|
$315,000
$28.47 P/Share
|
|
Jun 12
2023
|
Joan E Herman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,555
+10.53%
|
-
|
|
May 24
2023
|
Patrick R. O'Neil EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct |
1,527
-3.65%
|
$62,607
$41.7 P/Share
|
|
May 22
2023
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,931
-1.71%
|
$197,240
$40.14 P/Share
|
|
Apr 18
2023
|
Joseph Baroldi EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,880
-26.85%
|
$139,680
$36.5 P/Share
|
|
Apr 18
2023
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
SELL
Open market or private sale
|
Direct |
2,582
-9.6%
|
$92,952
$36.5 P/Share
|
|
Apr 18
2023
|
Brian Birchler EVP, Corp and Development Ops |
SELL
Open market or private sale
|
Direct |
672
-1.81%
|
$24,192
$36.5 P/Share
|
|
Apr 17
2023
|
Joseph Baroldi EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,838
+42.86%
|
-
|
|
Apr 17
2023
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
5,667
+17.4%
|
-
|
|
Apr 17
2023
|
Brian Birchler EVP, Corp and Development Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+4.8%
|
-
|